Coverage
-
November 08, 2021
A whistleblower has voluntarily dropped his 19-year-old False Claims Act lawsuit alleging the drugmaker Sanofi U.S. Services Inc. misleadingly promoted off-label uses for its cancer therapy drug, after the parties reached a confidential settlement less than three months before the case was set for trial.
6 other articles on this case.
View all »